IDEAL-CRT: A phase I/II trial of isotoxic dose-escalated radiotherapy and concurrent chemotherapy in patients with stage II/III non-small cell lung cancer

David B. Landau, Laura Hughes, Angela Baker, Andrew T. Bates, Michael C. Bayne, Nicholas Counsell, Ange Garcia-Alonso, Susan V. Harden, Jonathan D. Hicks, Simon R. Hughes, Marianne C. Illsley, Iftekhar Khan, Virginia Laurence, Zafar Malik, Helen Mayles, William PM. Mayles, Elizabeth Miles, Nazia Mohammed, Yenting Ngai, Emma ParsonsJames Spicer, Paula Wells, Dean Wilkinson, John D. Fenwick

Research output: Contribution to journal › Article › peer-review

43 Citations (Scopus)
152 Downloads (Pure)

Fingerprint

Dive into the research topics of 'IDEAL-CRT: A phase I/II trial of isotoxic dose-escalated radiotherapy and concurrent chemotherapy in patients with stage II/III non-small cell lung cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science